BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Isabel Conde, Carmen Vinaixa, Marina Berenguer. Cirrosis por hepatitis C. Estado actualMedicina Clínica 2017; 148(2): 78 doi: 10.1016/j.medcli.2016.09.019
2
Stefania Notari, Massimo Tempestilli, Gabriele Fabbri, Raffaella Libertone, Andrea Antinori, Adriana Ammassari, Chiara Agrati. UPLC–MS/MS method for the simultaneous quantification of sofosbuvir, sofosbuvir metabolite (GS-331007) and daclatasvir in plasma of HIV/HCV co-infected patientsJournal of Chromatography B 2018; 1073: 183 doi: 10.1016/j.jchromb.2017.12.018
3
Marleen H. M. Hessel, Adam F. Cohen, Robert Rissmann. Sofosbuvir and daclatasvirBritish Journal of Clinical Pharmacology 2016; 82(3): 878 doi: 10.1111/bcp.13011
4
Isabel Oriol, Laura Lladó, Marina Vila, Carme Baliellas, Fe Tubau, Núria Sabé, Joan Fabregat, Jordi Carratalà, Salvatore Gruttadauria. The Etiology, Incidence, and Impact of Preservation Fluid Contamination during Liver TransplantationPLOS ONE 2016; 11(8): e0160701 doi: 10.1371/journal.pone.0160701
5
Maissa El-Raziky, Marwa Khairy, Ahmed Fouad, Ahmed Salama, Aisha Elsharkawy, Omnia Tantawy. Effect of Direct-Acting Agents on Fibrosis Regression in Chronic Hepatitis C Virus Patients' Treatment Compared with Interferon-Containing RegimensJournal of Interferon & Cytokine Research 2018; 38(3): 129 doi: 10.1089/jir.2017.0137
6
Stacey B. Prenner, Lisa B. VanWagner, Steven L. Flamm, Riad Salem, Robert J. Lewandowski, Laura Kulik. Hepatocellular carcinoma decreases the chance of successful hepatitis C virus therapy with direct-acting antiviralsJournal of Hepatology 2017; 66(6): 1173 doi: 10.1016/j.jhep.2017.01.020
7
Marcello Persico, Andrea Aglitti, Michele Milella, Carmine Coppola, Vincenzo Messina, Ernesto Claar, Ivan Gentile, Fernando Sogari, Paola Pierri, Lorenzo A. Surace, Filomena Morisco, Paolo Tundo, Giuseppina Brancaccio, Gaetano Serviddio, Pietro Gatti, Antonio P. Termite, Giovan G. Di Costanzo, Benedetto Caroleo, Raffaele Cozzolongo, Nicola Coppola, Annamaria Longo, Luca Fontanella, Alessandro Federico, Valerio Rosato, Irene Terrenato, Mario Masarone. Real‐life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL studyLiver International 2019; 39(10): 1852 doi: 10.1111/liv.14170
8
Isabel Conde, Carmen Vinaixa, Marina Berenguer. Hepatitis C-related cirrhosis. Current statusMedicina Clínica (English Edition) 2017; 148(2): 78 doi: 10.1016/j.medcle.2016.09.035
9
Hung-Chang Hung, Hsien-Hua Liao, Shiuan-Chih Chen, Shih-Ming Tsao, Yuan-Ti Lee. Maintenance interferon therapy in chronic hepatitis C patients who failed initial antiviral therapyMedicine 2019; 98(19): e15563 doi: 10.1097/MD.0000000000015563
10
Katerina Kassela, Ioannis Karakasiliotis, Stefanos Charpantidis, John Koskinas, Theodora Mylopoulou, Konstantinos Mimidis, Christoph Sarrazin, Georgios Grammatikos, Penelope Mavromara. High prevalence of antibodies to core+1/ARF protein in HCV-infected patients with advanced cirrhosis Journal of General Virology 2017; 98(7): 1713 doi: 10.1099/jgv.0.000851
11
Esther González-Almela, Hugh Williams, Miguel A. Sanz, Luis Carrasco. The Initiation Factors eIF2, eIF2A, eIF2D, eIF4A, and eIF4G Are Not Involved in Translation Driven by Hepatitis C Virus IRES in Human CellsFrontiers in Microbiology 2018; 9 doi: 10.3389/fmicb.2018.00207
12
Anna Jakubowska, Grzegorz Żuchowski, Katarzyna Kulig. Cyclic sulfates as useful tools in the asymmetric synthesis of 1-aminocyclopropane-1-carboxylic acid derivativesTetrahedron: Asymmetry 2015; 26(21-22): 1261 doi: 10.1016/j.tetasy.2015.09.013
13
Tien S Dong, Elizabeth S Aby, Jihane N Benhammou, Jenna Kawamoto, Steven-Huy Han, Folasade P May, Joseph R Pisegna. Metabolic syndrome does not affect sustained virologic response of direct-acting antivirals while hepatitis C clearance improves hemoglobin A1cWorld Journal of Hepatology 2018; 10(9): 612-621 doi: 10.4254/wjh.v10.i9.612
14
S. Tsiomita, U. Georgopoulou, P.P. Doumba, J. Koskinas, K. Adamidis, C. Papaloukas, G. Thyphronitis. Evaluation of alternative serum biomarkers to monitor the progression of chronic HBV and HCV infectionInfection, Genetics and Evolution 2018; 58: 17 doi: 10.1016/j.meegid.2017.12.002